3-Alkyl- and 3-amido-isothiazoloquinolin-4-ones as ligands for the benzodiazepine site of GABAA receptors

被引:6
作者
Nilsson, Jakob [1 ]
Nielsen, Elsebet Ostergaard [2 ]
Liljefors, Tommy [3 ]
Nielsen, Mogens [3 ]
Sterner, Olov [1 ]
机构
[1] Lund Univ, Div Organ Chem, SE-22100 Lund, Sweden
[2] NeuroSearch AS, DK-2750 Ballerup, Denmark
[3] Univ Copenhagen, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark
关键词
3-Alkyl-6-methylisothiazolo[5,4-b]quinolin-4(9H)-ones; 3-Amido-6-methylisothiazolo[5,4-b]quinolin-4(9H)-ones; Benzodiazepine binding site; GABA(A) receptors; Pharmacophore model; BINDING; PHARMACOLOGY; DERIVATIVES; AFFINITY;
D O I
10.1016/j.bioorg.2011.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on a pharmacophore model of the benzodiazepine binding site of the GABA(A) receptors, developed with synthetic flavones and potent 3-carbonylquinolin-4-ones, 3-alkyl- and 3-amido-6-methylisothiazoloquinolin-4-ones were designed, prepared and assayed. The suggestion that the interaction between the hydrogen bond donor site H1 with the 3-carbonyl oxygen in 3-carbonylquinolin-4-ones can be replaced by an interaction between H1 and N-2 in the isothiazoloquinolin-4-ones, was confirmed. As with the 3-carbonylquinolin-4-ones, the length of the chain in position 3 is critical for an efficient interaction with the lipophilic pockets of the pharmacophore model. The most potent 3-alkyl derivative, 3-pentyl-6-methylisothiazoloquinolin-4-one, has an affinity (K-i value) for the benzodiazepine binding site of the GABA(A) receptors of 13 nM. However, by replacing the 3-pentyl with a 3-butyramido group an even more potent compound was obtained, with a K-i value of 2.8 nM, indicating that the amide function facilitates additional interactions with the binding site. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 10 条
[1]  
Choi JH, 2003, SYNLETT, P166
[2]   Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABAA receptor complex [J].
Dekermendjian, K ;
Kahnberg, P ;
Witt, MR ;
Sterner, O ;
Nielsen, M ;
Liljefors, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) :4343-4350
[3]   Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABAA receptor [J].
Kahnberg, P ;
Lager, E ;
Rosenberg, C ;
Schougaard, J ;
Camet, L ;
Sterner, O ;
Nielsen, EO ;
Nielsen, M ;
Liljefors, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) :4188-4201
[4]   4-quinolone derivatives:: High-affinity ligands at the benzodiazepine site of brain GABAA receptors. synthesis, pharmacology, and pharmacophore modeling [J].
Lager, E ;
Andersson, P ;
Nilsson, J ;
Pettersson, I ;
Nielsen, EO ;
Nielsen, M ;
Sterner, O ;
Liljefors, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (08) :2526-2533
[5]   Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors [J].
Lager, Erik ;
Nilsson, Jakob ;
Nielsen, Elsebet Ostergaard ;
Nielsen, Mogens ;
Liljefors, Tommy ;
Sterner, Olov .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (14) :6936-6948
[6]   Studies on pyridonecarboxylic acids. V. A practical synthesis of ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate, a key intermediate for the new tricyclic quinolone, prulifloxacin (NM441) and versatile new syntheses of the 2-thioquinoline skeleton [J].
Matsuoka, M ;
Segawa, J ;
Makita, Y ;
Ohmachi, S ;
Kashima, T ;
Nakamura, K ;
Hattori, M ;
Kitano, M ;
Kise, M .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1997, 34 (06) :1773-1779
[7]   Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABAA receptors [J].
Nilsson, Jakob ;
Nielsen, Elsebet Ostergaard ;
Liljefors, Tommy ;
Nielsen, Mogens ;
Sterner, Olov .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (21) :5713-5716
[8]   Triazoloquinazolinediones as novel high affinity ligands for the benzodiazepine site of GABAA receptors [J].
Nilsson, Jakob ;
Gidlof, Ritha ;
Nielsen, Elsebet Ostergaard ;
Liljefors, Tommy ;
Nielsen, Mogens ;
Sterner, Olov .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) :111-121
[9]  
Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4
[10]  
Zhang W, 1995, Drug Des Discov, V12, P193